| | Class 2 Device Recall VITEK 2 Gramnegative AST Test Kits |  |
| Date Initiated by Firm | June 26, 2025 |
| Date Posted | September 29, 2025 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-2671-2025 |
| Recall Event ID |
97269 |
| Product Classification |
System, test, automated, antimicrobial susceptibility, short incubation - Product Code LON
|
| Product | VITEK 2 Gram-negative AST Test Kits (Cards) containing Colistin formulation cs02n.
VITEK 2 is an automated system consisting of instruments, software and reagent cards designed for the identification and antimicrobial susceptibility testing of bacteria and yeast.
Export only |
| Code Information |
Material Number/Material Description/Batch Number:
423936 AST-N412 TEST KIT 20 CARDS 0143139204
423936 AST-N412 TEST KIT 20 CARDS 0143254504
423936 AST-N412 TEST KIT 20 CARDS 0143303504
424196 AST-N427 TEST KIT 20 CARDS 0542849204
424196 AST-N427 TEST KIT 20 CARDS 0543190104
424196 AST-N427 TEST KIT 20 CARDS 0543266504
424196 AST-N427 TEST KIT 20 CARDS 0542951404
424196 AST-N427 TEST KIT 20 CARDS 0543190104
424196 AST-N427 TEST KIT 20 CARDS 0543289404
424499 AST-N438 TEST KIT 20 CARDS 0703181504
424499 AST-N438 TEST KIT 20 CARDS 0703218104
424499 AST-N438 TEST KIT 20 CARDS 0703273104
424499 AST-N438 TEST KIT 20 CARDS 0703125104
424501 AST-N439 TEST KIT 20 CARDS 0723192104
424501 AST-N439 TEST KIT 20 CARDS 0723048404
424501 AST-N439 TEST KIT 20 CARDS 0722971504
424501 AST-N439 TEST KIT 20 CARDS 0723237504
424501 AST-N439 TEST KIT 20 CARDS 0722860204
424502 AST-N440 TEST KIT 20 CARDS 0733170404
424502 AST-N440 TEST KIT 20 CARDS 0733317504
424502 AST-N440 TEST KIT 20 CARDS 0733170404
424541 AST-N443 TEST KIT 20 CARDS 0773230404
424541 AST-N443 TEST KIT 20 CARDS 0773247404
424541 AST-N443 TEST KIT 20 CARDS 0772911104
424587 AST-N444 TEST KIT 20 CARDS 0802553214
424587 AST-N444 TEST KIT 20 CARDS 0802553204
424620 AST-N447 TEST KIT 20 CARDS 0853198104
424620 AST-N447 TEST KIT 20 CARDS 0853247204
424633 AST-N448 TEST KIT 20 CARDS 0862971204
424633 AST-N448 TEST KIT 20 CARDS 0863202504
424633 AST-N448 TEST KIT 20 CARDS 0863296504
424839 AST-N462 TEST KIT 20 CARDS No Lots
424840 AST-N463 TEST KIT 20 CARDS No Lots
424842 AST-N465 TEST KIT 20 CARDS No Lots
424891 AST-N475 TEST KIT 20 CARDS 1703184204
424891 AST-N475 TEST KIT 20 CARDS 1703225504
424934 AST-N476 TEST KIT 20 CARDS 1713192504
425019 AST-N477 TEST KIT 20 CARDS 1733184104
425019 AST-N477 TEST KIT 20 CARDS 1733205204
425019 AST-N477 TEST KIT 20 CARDS 1733205214
424197 AST-XN21 TEST KIT 20 CARDS 0493174204
424197 AST-XN21 TEST KIT 20 CARDS 0493310504
424199 AST-XN22 TEST KIT 20 CARDS 0552981204
424199 AST-XN22 TEST KIT 20 CARDS 0553156204
424351 AST-XN24 TEST KIT 20 CARDS 0653042204
424351 AST-XN24 TEST KIT 20 CARDS 0653217504
424394 AST-XN25 TEST KIT 20 CARDS 0662155104
424394 AST-XN25 TEST KIT 20 CARDS 0662553204
424586 AST-XN28 TEST KIT 20 CARDS 0793210504
424586 AST-XN28 TEST KIT 20 CARDS 0793265504
424586 AST-XN28 TEST KIT 20 CARDS 0793295504
424586 AST-XN28 TEST KIT 20 CARDS 0793210504
424604 AST-XN29 TEST KIT 20 CARDS 0822932204
424604 AST-XN29 TEST KIT 20 CARDS 0823262504
424810 AST-XN35 TEST KIT 20 CARDS 1323087204
424888 AST-XN37 TEST KIT 20 CARDS 1693079204
AST-XN25 424394 Australia AST-N412 423936 Thailand AST-XN21 424197 Turkey AST-XN22 424199 Iberia AST-N427 424196 Iberia AST-XN24 424351 Germany AST-N439 424501 Italy AST-N440 424502 Italy AST-XN28 424586 France AST-N443 424541 France, Spain & Portugal AST-N444 424587 Russia AST-N447 424620 Netherlands AST-N448 424633 Israel AST-XN35 424810 Poland AST-N462 424839 Taiwan AST-N463 424840 Taiwan AST-N465 424842 Taiwan AST-XN37 424888 Japan AST-N475 424891 Pakistan AST-N476 424934 Pakistan AST-N477 425019 India AST-N438 424499 Italy AST-XN29 424604 Japan |
Recalling Firm/ Manufacturer |
bioMerieux, Inc. 100 Rodolphe St Durham NC 27712-9402
|
| For Additional Information Contact | bioMerieux Customer Service Center 800-682-2666 |
Manufacturer Reason for Recall | Potential for false resistant results for Colistin (cs02n) with multi-drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii complex used in specific cards |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | On 06/27/2025, the firm sent an "URGENT FIELD SAFETY NOTICE" letter to customer informing them that VITEK 2 users, who are using VITEK 2 GN-AST cards with Colistin formulation, cs02n, have reported obtaining false resistant Colistin results with Acinetobacter baumannii complex and Pseudomonas aeruginosa isolates.
Customers are required to:
bioMrieux recommends you confirm any resistant colistin (cs02n) results for multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii complex isolates via an alternate method for all existing and future AST cards with cs02n.
If appropriate for your laboratory, create a custom bioART rule to show when resistant colistin (cs02n) results are obtained for Pseudomonas aeruginosa and Acinetobacter baumannii complex isolates (refer to the VITEK 2 Software User Manual for instructions).
Based on individual facility policy, you may wish to perform retrospective review of resistant results.
Distribute this information to all appropriate personnel in your laboratory, retain a copy in your files, and forward this information to all parties that may use this product, including others to whom you may have transferred the product.
Complete the Acknowledgement Form in Attachment A and return it to your local bioMrieux representative to confirm receipt of this notice. It is important that you return the acknowledgement form to bioMrieux even if you determine that this product correction notice does not impact your facility.
For questions or further assistance, contact the local bioMerieux Customer Service Representative. |
| Quantity in Commerce | 235269 cards |
| Distribution | International distribution in the countries of Albania, Armenia, Australia, Austria, Belgium, Bosnia, Bulgaria, China, Croatia, Cyprus, Czech Republic/Slovakia, France, Germany, Greece, Iberia, India, Israel, Italy, Japan, Lithuania, Macedonia, Malaysia/Brunei, Moldova, Netherlands, Pakistan, Poland, Portugal, Romania, Russia, Serbia, South Korea, Spain, Switzerland, Taiwan, Thailand, and Turkey. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|